Tags

Type your tag names separated by a space and hit enter

13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan.
BMC Nephrol 2015; 16:110BN

Abstract

BACKGROUND

Chronic hepatitis B virus (HBV) infection and chronic kidney disease (CKD) have high prevalences in Taiwan and worldwide. However, the association of untreated chronic hepatitis B virus (HBV) infection with chronic kidney disease (CKD) remains unclear.

METHODS

This cohort study used claims data in the Taiwan National Health Insurance Research Database in 1996-2010, in which all diseases were classified by ICD-9-CM codes. We identified 17796 adults who had chronic HBV infection and did not take nucleos(t)ide analogues from 1998 to 2010 and also randomly selected 71184 matched controls without HBV in the same dataset. Cumulative incidences and adjusted hazard ratio (aHR) of incident CKD were evaluated through the end of 2010 after adjusting for competing mortality.

RESULTS

The risk of CKD was significantly higher in the HBV cohort (13-year cumulative incidence, 6.2 %; 95 % confidence interval [CI], 5.4-7.1 %) than in the non-HBV cohort (2.7 %; 95 % CI, 2.5-3.0 %) (p < 0.001), and the aHR was 2.58 (95 % CI, 1.95-3.42; p < 0.001). Multivariable stratified analysis further verified significant associations of CKD with HBV in men of any age (aHR, 2.98; 95 % CI, 2.32-3.83, p < 0.001 for men aged <50 years; aHR, 1.58; 95 % CI, 1.31-1.91, p < 0.001 for men aged ≧ 50 years) and women under the age of 50 (aHR, 2.99; 95 % CI, 2.04-4.42, p < 0.001), but no significant association in women aged 50 or over.

CONCLUSION

Untreated chronic HBV infection is associated with increased risk of CKD. Hence, high-risk HBV-infected subjects should have targeted monitoring for the development of CKD.

Authors+Show Affiliations

Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, No. 2, Minsheng Rd., Dalin Township, Chiayi, County 622, Taiwan. chenyichun0320@yahoo.com.tw. School of Medicine, Tzu Chi University, Hualien, Taiwan. chenyichun0320@yahoo.com.tw.School of Medicine, Tzu Chi University, Hualien, Taiwan. alineycc@gmail.com. Division of Hematology-Oncology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan. alineycc@gmail.com.Department and Graduate Institute of Public Health, College of Medicine, National Cheng Hung University, Tainan, Taiwan. cyli99@mail.ncku.edu.tw. Department of Public Health, College of Public Health, China Medical University, Taichung, Taiwan. cyli99@mail.ncku.edu.tw.School of Medicine, Tzu Chi University, Hualien, Taiwan. df254246@tzuchi.com.tw. Department of Radiation Oncology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chiayi, Taiwan. df254246@tzuchi.com.tw.

Pub Type(s)

Journal Article

Language

eng

PubMed ID

26199000

Citation

Chen, Yi-Chun, et al. "13-year Nationwide Cohort Study of Chronic Kidney Disease Risk Among Treatment-naïve Patients With Chronic Hepatitis B in Taiwan." BMC Nephrology, vol. 16, 2015, p. 110.
Chen YC, Su YC, Li CY, et al. 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan. BMC Nephrol. 2015;16:110.
Chen, Y. C., Su, Y. C., Li, C. Y., & Hung, S. K. (2015). 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan. BMC Nephrology, 16, p. 110. doi:10.1186/s12882-015-0106-5.
Chen YC, et al. 13-year Nationwide Cohort Study of Chronic Kidney Disease Risk Among Treatment-naïve Patients With Chronic Hepatitis B in Taiwan. BMC Nephrol. 2015 Jul 22;16:110. PubMed PMID: 26199000.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - 13-year nationwide cohort study of chronic kidney disease risk among treatment-naïve patients with chronic hepatitis B in Taiwan. AU - Chen,Yi-Chun, AU - Su,Yu-Chieh, AU - Li,Chung-Yi, AU - Hung,Shih-Kai, Y1 - 2015/07/22/ PY - 2015/03/06/received PY - 2015/07/02/accepted PY - 2015/7/23/entrez PY - 2015/7/23/pubmed PY - 2016/3/25/medline SP - 110 EP - 110 JF - BMC nephrology JO - BMC Nephrol VL - 16 N2 - BACKGROUND: Chronic hepatitis B virus (HBV) infection and chronic kidney disease (CKD) have high prevalences in Taiwan and worldwide. However, the association of untreated chronic hepatitis B virus (HBV) infection with chronic kidney disease (CKD) remains unclear. METHODS: This cohort study used claims data in the Taiwan National Health Insurance Research Database in 1996-2010, in which all diseases were classified by ICD-9-CM codes. We identified 17796 adults who had chronic HBV infection and did not take nucleos(t)ide analogues from 1998 to 2010 and also randomly selected 71184 matched controls without HBV in the same dataset. Cumulative incidences and adjusted hazard ratio (aHR) of incident CKD were evaluated through the end of 2010 after adjusting for competing mortality. RESULTS: The risk of CKD was significantly higher in the HBV cohort (13-year cumulative incidence, 6.2 %; 95 % confidence interval [CI], 5.4-7.1 %) than in the non-HBV cohort (2.7 %; 95 % CI, 2.5-3.0 %) (p < 0.001), and the aHR was 2.58 (95 % CI, 1.95-3.42; p < 0.001). Multivariable stratified analysis further verified significant associations of CKD with HBV in men of any age (aHR, 2.98; 95 % CI, 2.32-3.83, p < 0.001 for men aged <50 years; aHR, 1.58; 95 % CI, 1.31-1.91, p < 0.001 for men aged ≧ 50 years) and women under the age of 50 (aHR, 2.99; 95 % CI, 2.04-4.42, p < 0.001), but no significant association in women aged 50 or over. CONCLUSION: Untreated chronic HBV infection is associated with increased risk of CKD. Hence, high-risk HBV-infected subjects should have targeted monitoring for the development of CKD. SN - 1471-2369 UR - https://www.unboundmedicine.com/medline/citation/26199000/13_year_nationwide_cohort_study_of_chronic_kidney_disease_risk_among_treatment_naïve_patients_with_chronic_hepatitis_B_in_Taiwan_ L2 - https://www.biomedcentral.com/1471-2369/16/110 DB - PRIME DP - Unbound Medicine ER -